Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05516524 · ClinicalTrials.gov registry record · NA
HSAT for OSA Management in Children
A NA study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT05516524: Completed NA study, sponsored by Children's Hospital of Philadelphia.
NCT05516524 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 62 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05516524, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
This clinical trial will compare the diagnostic accuracy of type II HSAT with PSG for determining OSA status following treatment with adenotonsillectomy in children
Primary Outcome
Correlation will be assessed in all participants completing PSG and HSAT using the OAHI from both tests
Interventions
- DIAGNOSTIC_TEST PSG
- DIAGNOSTIC_TEST Home sleep apnea test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2022-12-01 |
| Est. Completion | 2025-09-17 |
| Phase | NA |
What the finished NCT05516524 record still lists
NCT05516524 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which PSG is the first listed.
NCT05516524 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05516524 about?
NCT05516524 is a clinical study titled "HSAT for OSA Management in Children". This clinical trial will compare the diagnostic accuracy of type II HSAT with PSG for determining OSA status following treatment with adenotonsillectomy in children
What is the current status of trial NCT05516524?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2022-12-01. Estimated completion is 2025-09-17.
What interventions are being tested in trial NCT05516524?
The interventions under investigation include: PSG (DIAGNOSTIC_TEST), Home sleep apnea test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05516524?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05516524's enrollment target sits among peer trials
62 1157th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI